Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Levy

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2008
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor ageNazia Selzner, Nigel Girgrah, Les Lilly, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2015
Recipient factors associated with having a potential living donor for liver transplantationAdam Doyle, Rania N Rabie, Arastoo Mokhtari, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2016
Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant RecipientsJosh Levitsky, David Goldberg, Abigail R Smith, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 19, 2011
Living donor hepatectomy: the importance of the residual liver volumeTrevor W Reichman, Charbel Sandroussi, Solomon M Azouz, et al.
Plos Neglected Tropical Diseases|May 9, 2015
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in MiceJunhua Wang, Dominique A Vuitton, Norbert Müller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2004
Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patientsMark S Cattral, Michele Molinari, Charles M Vollmer, et al.
Seminars in Liver Disease|March 23, 2018
Surgical Complications after Right Hepatectomy for Live Liver Donation: Largest Single-Center Western World ExperienceAndre Gorgen, Nicolas Goldaracena, Wei Zhang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2015
Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubationJan Knaak, Mark McVey, Fateh Bazerbachi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejectionQin Ning, Yi Sun, Meifang Han, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 28, 2006
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimusGary Levy, Gian Luca Grazi, Fernando Sanjuan, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 26, 2008
The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor ageNazia Selzner, Nigel Girgrah, Les Lilly, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 21, 2015
Recipient factors associated with having a potential living donor for liver transplantationAdam Doyle, Rania N Rabie, Arastoo Mokhtari, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2016
Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant RecipientsJosh Levitsky, David Goldberg, Abigail R Smith, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 19, 2011
Living donor hepatectomy: the importance of the residual liver volumeTrevor W Reichman, Charbel Sandroussi, Solomon M Azouz, et al.
Plos Neglected Tropical Diseases|May 9, 2015
Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in MiceJunhua Wang, Dominique A Vuitton, Norbert Müller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2004
Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patientsMark S Cattral, Michele Molinari, Charles M Vollmer, et al.
Seminars in Liver Disease|March 23, 2018
Surgical Complications after Right Hepatectomy for Live Liver Donation: Largest Single-Center Western World ExperienceAndre Gorgen, Nicolas Goldaracena, Wei Zhang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 14, 2015
Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubationJan Knaak, Mark McVey, Fateh Bazerbachi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejectionQin Ning, Yi Sun, Meifang Han, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 28, 2006
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimusGary Levy, Gian Luca Grazi, Fernando Sanjuan, et al.
Pageof 8